Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
10.78
+1.00 (10.22%)
At close: Nov 6, 2026, 4:00 PM EST
10.75
-0.03 (-0.28%)
After-hours: Nov 6, 2026, 7:59 PM EST
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or 21.32% compared to the previous year. That makes Novavax the 16,976th largest employer in the world and 2,371st in the United States.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$549,598
Profits / Employee
-$102,439
Market Cap
1.78B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Agios Pharmaceuticals | 540 |
| Stoke Therapeutics | 170 |
| Zenas BioPharma | 167 |
| Maze Therapeutics | 141 |
| Absci | 140 |
| Mesoblast | 108 |
| Lycia Therapeutics | 31 |
NVAX News
- 1 day ago - Novavax price target lowered to $16 from $18 at B. Riley - TheFly
- 1 day ago - Novavax price target lowered to $7 from $8 at BofA - TheFly
- 2 days ago - Novavax Earnings Call Transcript: Q3 2026 - Transcripts
- 2 days ago - Novavax Earnings release: Q3 2026 - Filings
- 2 days ago - Novavax Slides: Q3 2026 - Filings
- 2 days ago - Novavax Quarterly report: Q3 2026 - Filings
- 2 days ago - Novavax raises FY26 adjusted revenue view to $385M-$415M from $235M-$275M - TheFly
- 2 days ago - Novavax reports Q3 EPS (19c), consensus (42c) - TheFly